Otsuka, Yuki
Oishi, Akio http://orcid.org/0000-0002-0977-9458
Suda, Kenji
Tsujikawa, Akitaka
Kurakazu, Toshiaki
Article History
Received: 23 June 2018
Revised: 10 November 2018
Accepted: 22 December 2018
First Online: 6 January 2019
Compliance with ethical standards
:
: Akio Oishi received a grant from Novartis (Basel, Switzerland) and speaker’s honoraria from Alcon (Tokyo, Japan), Bayer (Leverkusen, Germany), and Santen (Osaka, Japan); Akitaka Tsujikawa received grants from Novartis, Santen, Bayer, HOYA (Tokyo, Japan), Kowa (Nagoya, Japan), Pfizer (New York, NY), AMO Japan (Tokyo, Japan), Senju (Osaka, Japan), Wakamoto (Tokyo, Japan), Alcon, Japan Medical Industry Association (Tokyo, Japan), Tomey (Nagoya, Japan), JFC Sales Plan (Tokyo, Japan), and Atsuzawa Prosthesis (Tokyo, Japan) and speaker’s honoraria from Alcon, Bayer, Santen, Novartis, Pfizer, Senju, Nidek (Gamagori, Japan), AMO Japan, Kowa, Chugai (Tokyo, Japan), Sanwa Kagaku (Nagoya, Japan), Kyoto Soyaku (Kyoto, Japan), HOYA, Otsuka (Tokyo, Japan), Daiichi Sankyo (Tokyo, Japan), and Wakamoto; Toshiaki Kurakazu received speaker’s honoraria from Santen, HOYA, Kowa, Pfizer, AMO Japan, Senju, Alcon, Japan Medical Industry Association, and Nidek. The following authors have no financial disclosures: Yuki Otsuka and Kenji Suda.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was reviewed and approved by the Institutional Review Board and Ethics Committee (IRB/EC) of Hidaka Medical Center (Toyooka Japan). Because of this study’s retrospective nature, the IRB/EC waived the requirement of informed consent.